The University of Queensland

A randomized, multicenter, double-blind, placebo-controlled, 18 month study of the efficacy of xaliproden in patients with mild to moderate dementia of the Alzheimer's type. Protocol No. EFC 2724. (2003–2008)

Grant type:

SANOFI - SYNTHELABO AUSTRALIA PTY LTD

Researchers:

• 

  Professor Gerard Byrne

  Mayne Professor of Psychiatry
  

  Medical School (Office & AME)

  Faculty of Medicine

Funded by:

Sanofi - Synthelabo Australia Pty Ltd